Methicillin-Resistant Staphylococcus aureus
"Methicillin-Resistant Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
| Descriptor ID |
D055624
|
| MeSH Number(s) |
B03.300.390.400.800.750.100.500 B03.353.500.750.750.100.500 B03.510.100.750.750.100.500 B03.510.400.790.750.100.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methicillin-Resistant Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Methicillin-Resistant Staphylococcus aureus".
This graph shows the total number of publications written about "Methicillin-Resistant Staphylococcus aureus" by people in this website by year, and whether "Methicillin-Resistant Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 4 | 1 | 5 |
| 2009 | 5 | 5 | 10 |
| 2010 | 5 | 5 | 10 |
| 2011 | 9 | 3 | 12 |
| 2012 | 4 | 1 | 5 |
| 2013 | 3 | 4 | 7 |
| 2014 | 5 | 3 | 8 |
| 2015 | 3 | 3 | 6 |
| 2016 | 4 | 8 | 12 |
| 2017 | 6 | 3 | 9 |
| 2018 | 4 | 2 | 6 |
| 2019 | 4 | 3 | 7 |
| 2020 | 5 | 2 | 7 |
| 2021 | 8 | 1 | 9 |
| 2022 | 9 | 0 | 9 |
| 2023 | 6 | 0 | 6 |
| 2024 | 3 | 3 | 6 |
| 2025 | 2 | 2 | 4 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methicillin-Resistant Staphylococcus aureus" by people in Profiles.
-
Parameter-Dependent Effects of Rose Bengal Photodynamic Antimicrobial Therapy on MRSA Inhibition and Corneal Cytokine Expression. Transl Vis Sci Technol. 2026 Apr 06; 15(4):14.
-
Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activity. Nat Commun. 2026 Mar 15; 17(1).
-
N-benzyl-N-methyldithiocarbamate (BMDC) combines with metals to produce antimicrobial and anti-biofilm activity against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis. mSphere. 2026 Jan 27; 11(1):e0069125.
-
The antibacterial effect of human adipose-derived stem cells on LL-37-resistant bacteria. PLoS One. 2025; 20(10):e0333647.
-
The Microbiology and Clinical Presentation of Acute Bacterial Arthritis in Houston Area Children <5 Years Old in the Era of Molecular Diagnostics. Pediatr Infect Dis J. 2025 Mar 21; 44(8):735-741.
-
Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia. BMC Infect Dis. 2025 Feb 18; 25(1):231.
-
The First Report of t8463 and t605 spa Types in Methicillin-resistant Staphylococcus aureus isolated from ICUs in Rasht, Iran. Arch Razi Inst. 2024 Oct; 79(5):955-961.
-
Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection. Antimicrob Agents Chemother. 2024 11 06; 68(11):e0089824.
-
Penicillin susceptibility among Staphylococcus aureus skin and soft tissue infections at a children's hospital. Microbiol Spectr. 2024 Oct 03; 12(10):e0086924.
-
Methicillin-resistant Staphylococcus aureus in diabetic and non-diabetic foot infections. Int Wound J. 2024 Sep; 21(9):e70039.